West Pharmaceutical Services (WST) Return on Capital Employed (2010 - 2026)
West Pharmaceutical Services recorded quarterly Return on Capital Employed of 18.63% in Q1 2026, up 12.53% quarter-over-quarter from 16.56% in Q4 2025, and up 78.0% year-over-year from 10.47% in Q1 2025.
West Pharmaceutical Services' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 18.63% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 78.0% year-over-year to 18.63%; the TTM figure through Mar 2026 stood at 18.63% (up 78.0% YoY), while the FY2025 annual figure was 17.71%, down 17.0% from the prior year.
- Return on Capital Employed came in at 18.63% for Q1 2026 at West Pharmaceutical Services, up from 16.56% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 28.36% in Q2 2022 to a low of 16.56% in Q4 2025.
- A 5-year average of 21.2% and a median of 20.29% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed soared 653 bps in 2022 and plunged 783 bps in 2023, its largest moves.
- West Pharmaceutical Services' Return on Capital Employed stood at 24.9% in 2022, then retreated by 13 bps to 21.66% in 2023, then decreased by 15 bps to 18.33% in 2024, then slipped by 10 bps to 16.56% in 2025, then rose by 13 bps to 18.63% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 18.63%, 16.56%, and 17.32% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 5.02% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 25.95% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 18.63% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 19.44% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 6.60% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 12.74% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 13.02% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 12.04% |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn | 2.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.63% |
| Dec 31, 2025 | 16.56% |
| Sep 30, 2025 | 17.32% |
| Jun 30, 2025 | 18.28% |
| Mar 31, 2025 | 17.85% |
| Dec 31, 2024 | 18.33% |
| Sep 30, 2024 | 18.63% |
| Jun 30, 2024 | 20.16% |
| Mar 31, 2024 | 20.98% |
| Dec 31, 2023 | 21.66% |
| Sep 30, 2023 | 20.29% |
| Jun 30, 2023 | 20.52% |
| Mar 31, 2023 | 22.31% |
| Dec 31, 2022 | 24.90% |
| Sep 30, 2022 | 27.35% |
| Jun 30, 2022 | 28.36% |
| Mar 31, 2022 | 28.18% |
| Dec 31, 2021 | 28.56% |
| Sep 30, 2021 | 27.60% |
| Jun 30, 2021 | 25.47% |
| Mar 31, 2021 | 21.65% |
| Dec 31, 2020 | 18.62% |
| Sep 30, 2020 | 18.08% |
| Jun 30, 2020 | 17.33% |
| Mar 31, 2020 | 16.10% |
| Dec 31, 2019 | 15.48% |
| Sep 30, 2019 | 15.68% |
| Jun 30, 2019 | 15.73% |
| Mar 31, 2019 | 15.10% |
| Dec 31, 2018 | 14.31% |
| Sep 30, 2018 | 14.49% |
| Jun 30, 2018 | 14.96% |
| Mar 31, 2018 | 13.64% |
| Dec 31, 2017 | 13.96% |
| Sep 30, 2017 | 13.75% |
| Jun 30, 2017 | 13.77% |
| Mar 31, 2017 | 15.37% |
| Dec 31, 2016 | 13.14% |
| Sep 30, 2016 | 12.65% |
| Jun 30, 2016 | 9.18% |
| Mar 31, 2016 | 7.69% |
| Dec 31, 2015 | 9.41% |
| Sep 30, 2015 | 9.38% |
| Jun 30, 2015 | 13.33% |
| Mar 31, 2015 | 14.26% |
| Dec 31, 2014 | 12.83% |
| Sep 30, 2014 | 12.05% |
| Jun 30, 2014 | 11.45% |
| Mar 31, 2014 | 10.84% |
| Dec 31, 2013 | 11.35% |
| Sep 30, 2013 | 11.28% |
| Jun 30, 2013 | 10.43% |
| Mar 31, 2013 | 10.03% |
| Dec 31, 2012 | 10.52% |
| Sep 30, 2012 | 10.71% |
| Dec 31, 2011 | 9.49% |
| Sep 30, 2011 | 7.52% |
| Jun 30, 2011 | 7.33% |
| Mar 31, 2011 | 7.89% |
| Dec 31, 2010 | 8.04% |
| Sep 30, 2010 | 9.65% |